Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly, Nektar Partner On 'Stimulating' IL-2 Drug In Autoimmune Diseases

Jul 25 2017

• By Mandy Jackson

Business partners hands on top of each other symbolizing companionship

Related Content

Lilly Pays KeyBioscience $55m Up Front to Expand Its Early Diabetes Pipeline

Jun 09 2017

Billions On The Line With Celgene’s Partnered Pipeline

Jan 27 2017

Lilly Pays Nearly $1bn To Regain Migraine Candidate It Once Sold For $1m

Jan 19 2017

Tech Transfer: Lilly, Purdue University Work To Optimize Injectable Therapies

Jul 11 2017

Nektar Edges Into Immunotherapy With Better Interleukin-2 Drug

Oct 09 2015

Related Companies

Nektar Therapeutics

Eli Lilly and Company

Bristol Myers Squibb Company

Delinia, Inc.

Amgen, Inc.

Alkermes plc

CoLucid Pharmaceuticals, Inc.

Nordic Bioscience A/S

Purdue University

Additional Topics

Deals Business Strategies Commercial Immune Disorders Inflammation BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window